CIRILLO, EMILIA
 Distribuzione geografica
Continente #
AS - Asia 4.206
NA - Nord America 3.856
EU - Europa 2.735
SA - Sud America 474
Continente sconosciuto - Info sul continente non disponibili 187
AF - Africa 104
OC - Oceania 8
Totale 11.570
Nazione #
US - Stati Uniti d'America 3.697
SG - Singapore 1.775
RU - Federazione Russa 1.391
VN - Vietnam 882
CN - Cina 827
IT - Italia 472
BR - Brasile 360
HK - Hong Kong 270
DE - Germania 180
FR - Francia 159
CA - Canada 95
FI - Finlandia 92
BD - Bangladesh 90
GB - Regno Unito 85
IN - India 76
NL - Olanda 70
IE - Irlanda 69
JP - Giappone 64
UA - Ucraina 52
SE - Svezia 47
MX - Messico 46
AR - Argentina 43
KR - Corea 34
TR - Turchia 34
ZA - Sudafrica 29
IQ - Iraq 25
CI - Costa d'Avorio 24
AT - Austria 23
EC - Ecuador 23
PL - Polonia 23
ES - Italia 22
PH - Filippine 21
CO - Colombia 16
ID - Indonesia 16
TH - Thailandia 14
EG - Egitto 13
UZ - Uzbekistan 11
MA - Marocco 9
TW - Taiwan 9
BE - Belgio 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
KE - Kenya 7
PK - Pakistan 7
CL - Cile 6
IL - Israele 6
LT - Lituania 6
PY - Paraguay 6
VE - Venezuela 6
KZ - Kazakistan 5
PE - Perù 5
TN - Tunisia 5
UY - Uruguay 5
CH - Svizzera 4
CR - Costa Rica 4
DK - Danimarca 4
DZ - Algeria 4
EU - Europa 4
JO - Giordania 4
OM - Oman 4
ET - Etiopia 3
HU - Ungheria 3
JM - Giamaica 3
MT - Malta 3
MY - Malesia 3
PS - Palestinian Territory 3
PT - Portogallo 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CY - Cipro 2
CZ - Repubblica Ceca 2
GR - Grecia 2
HN - Honduras 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MM - Myanmar 2
NP - Nepal 2
RO - Romania 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AD - Andorra 1
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BW - Botswana 1
CD - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
LB - Libano 1
LC - Santa Lucia 1
Totale 11.374
Città #
Singapore 871
San Jose 521
Chandler 363
Ashburn 348
Moscow 329
Beijing 280
Santa Clara 257
Hong Kong 244
Ho Chi Minh City 230
Hanoi 171
Hefei 140
Los Angeles 130
The Dalles 119
New York 86
Buffalo 81
Dong Ket 80
Lauterbourg 80
Millbury 72
Tokyo 58
Nanjing 53
Napoli 53
Princeton 50
Boston 48
Dallas 48
Naples 45
Amsterdam 42
Jacksonville 41
Wilmington 41
Des Moines 38
Frankfurt am Main 37
Munich 37
São Paulo 37
Haiphong 36
Milan 35
Redondo Beach 33
Seattle 32
Da Nang 30
Houston 30
Council Bluffs 28
Chicago 27
London 27
Orem 26
Helsinki 25
Toronto 25
Brooklyn 23
Seoul 23
Atlanta 21
Montreal 21
Ottawa 21
Rome 21
Mexico City 20
Lawrence 19
Nuremberg 19
Warsaw 19
Chennai 17
Falkenstein 17
Turku 17
Düsseldorf 15
Nanchang 15
Phoenix 15
Poplar 15
Pune 15
Boardman 14
Dublin 14
Woodbridge 14
Biên Hòa 13
Falls Church 13
Rio de Janeiro 13
Quito 12
Tianjin 12
Vienna 11
Charlotte 10
Hebei 10
Manchester 10
Denver 9
Hải Dương 9
Johannesburg 9
Kochi 9
Quận Bình Thạnh 9
Stockholm 9
Tashkent 9
Thái Bình 9
Baghdad 8
Belo Horizonte 8
Cairo 8
Castellana Grotte 8
Pasadena 8
Querétaro 8
Roubaix 8
Bangkok 7
Bắc Giang 7
Changsha 7
City of London 7
Lappeenranta 7
Nairobi 7
Neenah 7
Ninh Bình 7
Thái Nguyên 7
Turin 7
Brasília 6
Totale 6.067
Nome #
Challenges in investigating patients with isolated decreased serum IgM: The SIMcal study 294
DiGeorge-like syndrome in a child with a 3p12.3 deletion involving miRNA-4273 born to a diabetic mother 244
Case report: EBV-related eye orbits and sinuses lymphohistiocytic infiltration responsive to rituximab in a patient with X lymphoproliferative syndrome type 1 198
Chronic mucocutaneous candidiasis, recurrent herpetic infections and suppurative eyelid infections in a patient carrying a novel gain-of-function mutation in the STAT1 DNA-binding domain 186
De novo 13q12.3q14.11 deletion involving BRCA2 gene in a patient with developmental delay, elevated IgM levels, transient ataxia and cerebellar hypoplasia, mimicking an A-T like phenotype. 184
Clinical, Immunological, and Functional Characterization of Six Patients with Very High IgM Levels 178
Intrathecal amphotericin B therapy in a patient with X-linked chronic granulomatous disease and refractory cerebral invasive aspergillosis 169
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 167
TLR9 signaling in patients with ectodermal dysplasia and immunodeficiency associated with Nuclear Factor Essential Modulator (NEMO) mutations 165
Immunodeficienze primitive: cosa c’è di nuovo 165
DiGeorge-like Syndrome in a Child with a 3p12.3 Deletion Involving MIR4273 Gene Born to a Mother with Gestational Diabetes Mellitus 163
CD4+ T Cell Defects in a Mulibrey Patient With Specific TRIM37 Mutations 162
Gastrointestinal involvement in patients affected with 22q11.2 deletion syndrome 160
A Nationwide Study of GATA2 Deficiency in Italy Reveals Novel Symptoms and Genotype–phenotype Association 157
Severe combined immunodeficiency-an update 156
Clinical, Immunological, and Molecular Features of Typical and Atypical Severe Combined Immunodeficiency: Report of the Italian Primary Immunodeficiency Network 156
Long term longitudinal follow-up of an AD-HIES cohort: the impact of early diagnosis and enrollment to IPINet centers on the natural history of Job’s syndrome 155
The Inborn Errors of Immunity—Virtual Consultation System Platform in Service for the Italian Primary Immunodeficiency Network: Results from the Validation Phase 154
Steroid treatment in Ataxia-Telangiectasia induces alterations of functional magnetic resonance imaging during prono-supination task. 154
Novel STAT1 gain of function mutation and suppurative infections 153
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality 152
Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET) 149
Phenotypic characterization and outcome of paediatric patients affected with haemophagocytic syndrome of unknown genetic cause. 148
Progressive Depletion of B and T Lymphocytes in Patients with Ataxia Telangiectasia: Results of the Italian Primary Immunodeficiency Network 148
X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management, and outcome of the disease. 145
Elevated IgM levels in a patient with a de novo 13Q12.3Q14.11 deletion, mimicking an A-T like phenotype 142
Diagnostics of Primary immunodeficiencies through next-generation sequencing 142
Rare solid tumors in a patient with Wiskott–Aldrich syndrome after hematopoietic stem cell transplantation: case report and review of literature 141
Understanding the Variability of 22q11.2 Deletion Syndrome: The Role of Epigenetic Factors 140
DiGeorge Syndrome 140
Health-Related Quality of Life and Emotional Difficulties in Chronic Granulomatous Disease: Data on Adult and Pediatric Patients from Italian Network for Primary Immunodeficiency (IPINet) 140
Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency 138
Unraveling the link between ectodermal disorders and primary immunodeficiencies 135
Consensus of the Italian Primary Immunodeficiency Network on the use and interpretation of genetic testing for diagnosing inborn errors of immunity 134
In Ataxia-Telangiectasia, Oral Betamethasone Administration Ameliorates Lymphocytes Functionality through Modulation of the IL-7/IL-7Rα Axis Paralleling the Neurological Behavior: A Comparative Report of Two Cases 134
Unbalanced Immune System: Immunodeficiencies and Autoimmunity 133
Consensus of the Italian Primary Immunodeficiency Network on transition management from pediatric to adult care in patients affected with childhood-onset inborn errors of immunity 133
Novel Findings into AIRE Genetics and Functioning: Clinical Implications 131
Otolarylogical features in a cohort of patients affected with 22q11.2 deletion syndrome: a monocentric survey 131
Intergenerational and intrafamilial phenotypic variability in 22q11.2 deletion syndrome subjects 130
Altered signaling through IL-12 receptor in children with very high serum IgE levels 128
Efficacy of very-low-dose betamethasone on neurological symptoms in ataxia-telangiectasia 126
Intergenerational familial phenotipic variability in 22Q11.2 subjects: a multicenter study within the italian primary immunodeficiencies network (IPINET) 126
Severe combined immunodeficiences: new and old scenarios 125
Complement system network in cell physiology and in human diseases 124
Three Unrelated Patients of Roma Ethnicity from a Single Center Carrying the Same Deletion in MYD88 Gene: A Founder Effect? 120
SCID-like phenotype associated with an inhibitory autoreactive immunoglobulin 120
A novel form of hyper-IgM syndrome 120
Evaluation of executive functions in subjects affected with 22Q11.2 deletion syndrome: a neuroanatomical hypothesis 120
Retrospective analysis of 21 pediatric patients affected with hemophagocytic syndrome of unknown genetic cause: clinical features and outcome 119
Minimum effective betamethasone dosage on the neurological phenotype in patients with Ataxia-Telangiectasia: a multicenter observer-blind study 119
Follow-up and outcome of symptomatic partial or absolute IgA deficiency in children 119
FOXN1 Deficiency: from the Discovery to Novel Therapeutic Approaches 118
Clinical Phenotype, Immunological Abnormalities, and Genomic Findings in Patients with DiGeorge Spectrum Phenotype without 22q11.2 Deletion 118
Respiratory Manifestations in Primary Immunodeficiencies: Findings From a Pediatric and Adult Cohort 117
Epigenetic Alterations in Inborn Errors of Immunity 117
Characterization of a WAS splice-site variant in a patient with Wiskott-Aldrich syndrome 115
NADPH Oxidase Deficiency: A Multisystem Approach 115
Clinical Manifestations of 22q11.2 Deletion Syndrome 115
SARS-CoV-2 Infection in the Immunodeficient Host: Necessary and Dispensable Immune Pathways 115
Chronic granulomatous disease with gastrointestinal presentation: diagnostic pitfalls and novel ultrastructural findings 114
Genetic basis of altered central tolerance and autoimmune diseases: a lesson from AIRE mutations 114
Neonatal alloimmune neutropenia: diagnosis and management of 31 Italian patients 113
A Bronchovascular Anomaly in a Patient With 22q11.2 Deletion Syndrome 113
Mechanisms of immune tolerance breakdown in inborn errors of immunity 110
In ataxia-Telangiectasia betamethasone response correlates inversely to cerebellar atrophy and directly to antioxidative capacity 109
In adult X-CGD patients, regulatory T cells are expanded while activated T cells display a NOX2-independent ROS increase 109
Estimate the minimum therpeutically effective dosage of short-term therapy with Betamethasone on neurologicaal symptoms in patients affected with Ataxia-Telangectasia 106
A case of Incontinentia Pigmenti associated with congenital absence of portal vein system and nodular regenerative hyperplasia 106
T-Cell Immunodeficiencies With Congenital Alterations of Thymic Development: Genes Implicated and Differential Immunological and Clinical Features 105
Cutaneous vasculitis in patients with autoimmune polyendocrine syndrome type 1: report of a case and brief review of the literature 102
MicroRNA dysregulation in ataxia telangiectasia 96
Case Report: Severe Rhabdomyolysis and Multiorgan Failure After ChAdOx1 nCoV-19 Vaccination 96
Clinical Features and Follow-Up in Patients with 22q11.2 Deletion Syndrome 93
Immunological Aspects of Kabuki Syndrome: A Retrospective Multicenter Study of the Italian Primary Immunodeficiency Network (IPINet) 93
A novel pathogenic variant causing POU3F3-related neurodevelopmental disorder in a child presenting with infantile epileptic spasms syndrome: Expanding the epileptic phenotype 92
The effects of betamethasone therapy on neurological functions in A-T patients 90
Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations 90
Reduced atherosclerotic burden in subjects with genetically determined low oxidative stress 89
In Ataxia-Teleangectasia betamethasone response correlates inversely to cerebellar atrophy and directly to antioxidative capacity. 88
Gamma chain transducing element: a shared pathway between endocrine and immune system 88
Intergenerational anticipation of disease onset in people with multiple autoimmune syndrome. 88
B cells from nuclear factor kB essential modulator deficient patients fail to differentiate to antibody secreting cells in response to TLR9 ligand 88
Two Brothers with Atypical UNC13D-Related Hemophagocytic Lymphohistiocytosis Characterized by Massive Lung and Brain Involvement 88
Allergic Manifestations of Inborn Errors of Immunity 87
Oral thrush and onychomycosis 80
Estimate the minimum therapeutically effective dosage of short term therapy with betamethasone on neurological symptoms in patients affected with Ataxia- Teleangectasia 79
Different Degrees of NADPH Oxidase 2 Regulation and In Vivo Platelet Activation: Lesson From Chronic Granulomatous Disease 76
Development of cancer surveillance guidelines in ataxia telangiectasia: A Delphi‐based consensus survey of international experts 59
In ataxia-teleangiectasia betamethasone response is inversely correlated to cerebellar atrophy and directly to antioxidative capacity. 56
Recurrent cold suppurative granulomatous lymphadenitis 51
Totale 11.570
Categoria #
all - tutte 35.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.750


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022438 0 0 1 7 4 15 1 17 75 49 110 159
2022/2023696 79 86 15 79 100 81 1 58 118 31 35 13
2023/2024404 12 63 34 26 26 38 8 46 31 10 81 29
2024/20252.998 119 134 20 23 109 240 227 207 190 314 1.156 259
2025/20265.945 574 436 586 543 1.051 215 686 265 711 359 151 368
2026/2027178 149 29 0 0 0 0 0 0 0 0 0 0
Totale 11.570